74. Clin Transl Oncol. 2018 Jun 18. doi: 10.1007/s12094-018-1909-1. [Epub ahead ofprint]Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.Colomer R(1), Aranda-López I(2), Albanell J(3), García-Caballero T(4), CiruelosE(5), López-García MÁ(6), Cortés J(7)(8)(9), Rojo F(10), Martín M(11),Palacios-Calvo J(12).Author information: (1)Departamento de Oncología Médica, Hospital Universitario La Princesa, C/Diego de León, 62, 28006, Madrid, Spain. rcolomer@seom.org.(2)Pathology Department, General University Hospital of Alicante, Alicante,Spain.(3)Medical Oncology Department, Mar University Hospital, Hospital del Mar MedicalResearch Institute (IMIM), Pompeu Fabra University, CIBERONC, Barcelona, Spain.(4)Pathology Department, University Hospital Complex of Santiago, Santiago deCompostela, Spain.(5)Medical Oncology Department, Doce de Octubre University Hospital, Madrid,Spain.(6)Pathology Department, Virgen del Rocio University Hospital, CIBERONC, Seville,Spain.(7)Medical Oncology Department, Ramón y Cajal University Hospital, Madrid, Spain.(8)Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.(9)Baselga Institute of Oncology (IOB), Madrid, Barcelona, Spain.(10)Pathology Department, Fundación Jiménez Díaz University Hospital, Madrid,Spain.(11)Medical Oncology Department, Gregorio Marañón University Hospital, CIBERONC, GEICAM, Madrid, Spain.(12)Pathology Department, Ramón y Cajal University Hospital, CIBERONC, IRYCIS andUniversity of Alcalá, Madrid, Spain. jose.palacios@salud.madrid.org.Erratum for    Clin Transl Oncol. 2018 Jul;20(7):815-826.On page 5 of the article, in the last paragraph of the section "Prognosticgenetic platforms: molecular phenotypes and translation to the clinic" a relevantdiscrepancy between the text and Table 1 could be misunderstood, therefore theparagraph was corrected.DOI: 10.1007/s12094-018-1909-1 PMID: 29916189 